Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 31, Issue 19, 2013, Pages 2469-2476

  Schmiegelow, Kjeld ^a   Levinsen, Mette Frandsen ^a   Attarbaschi, Andishe ^b   Baruchel, Andre ^c   Devidas, Meenakshi ^d   Escherich, Gabriele ^e   Gibson, Brenda ^g   Heydrich, Christiane ^f   Horibe, Keizo ^h   Ishida, Yasushi ⁱ   Liang, Der Cherng ^j   Locatelli, Franco ^k   Michel, Gérard ^c   Pieters, Rob ^m   Piette, Caroline ⁿ   Pui, Ching Hon ^o   Raimondi, Susana ^o   Silverman, Lewis ^p   Stanulla, Martin ^f   Stark, Batia ^q   Winick, Naomi ^r   Valsecchi, Maria Grazia ^l   more..

^a Rigshospitalet   (Denmark)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^h NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

ⁱ ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^j MACKAY MEMORIAL HOSPITAL   (Taiwan)

^k BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

^m SOPHIA CHILDREN S HOSPITAL   (Netherlands)

ⁿ Centre Hospitalier Regional de La Citadelle   (Belgium)

^o ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^p BOSTON CHILDREN S HOSPITAL   (United States)

^q SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^r UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIPODOPHYLLOTOXIN; MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BASAL CELL CARCINOMA; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MENINGIOMA; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PAROTID GLAND TUMOR; PRIORITY JOURNAL; SECOND MALIGNANT NEOPLASM; SKULL IRRADIATION; SOLID MALIGNANT NEOPLASM; SURVIVAL RATE; THYROID CARCINOMA; ACUTE GRANULOCYTIC LEUKEMIA; BRAIN TUMOR; DENMARK; KAPLAN MEIER METHOD; KARYOTYPE; MORTALITY; MULTICENTER STUDY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84883119415     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.0500     Document Type: Article

References (46)

1. Hijiya N, Hudson MM, Lensing S, et al: Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297:1207-1215, 2007
2. Schmiegelow K, Al-Modhwahi I, Andersen MK, et al: Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: Results from the NOPHO ALL-92 study. Blood 113:6077-6084, 2009
3. Prucker C, Attarbaschi A, Peters C, et al: Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: A population-based analysis of the Austrian Berlin-Frankfurt-Münster study group. Leukemia 23:1264-1269, 2009
4. Lund B, Åsberg A, Heyman M, et al: Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 56:551-559, 2011
5. Schmiegelow K, Forestier E, Hellebostad M, et al: Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 24:345-354, 2010
6. Kamps WA, van der Pal-de Bruin KM, Veer-man AJ, et al: Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia 24:309-319, 2010
7. Pui CH, Pei D, Sandlund JT, et al: Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24:371-382, 2010
8. Tsuchida M, Ohara A, Manabe A, et al: Long-term results of Tokyo Children’s Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia 24:383-396, 2010
9. Tsurusawa M, Shimomura Y, Asami K, et al: Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia. Leukemia 24:335-344, 2010
10. Silverman LB, Stevenson KE, O’Brien JE, et al: Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 24:320-334, 2010
11. Conter V, Aricò M, Basso G, et al: Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 24:255-264, 2010
12. Stary J, Jabali Y, Trka J, et al: Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic. Leukemia 24: 425-428, 2010
13. Gaynon PS, Angiolillo AL, Carroll WL, et al: Long-term results of the children’s cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children’s Oncology Group Report. Leukemia 24:285-297, 2010
14. Salzer WL, Devidas M, Carroll WL, et al: Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: A report from the Children’s Oncology Group. Leukemia 24:355-370, 2010
15. Möricke A, Zimmermann M, Reiter A, et al: Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24:265-284, 2010
16. Escherich G, Horstmann MA, Zimmermann M, et al: Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): Long-term results of trials 82, 85, 89, 92 and 97. Leukemia 24:298-308, 2010
17. Mitchell C, Richards S, Harrison CJ, et al: Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia 24:406-418, 2010
18. Olsen JH, Möller T, Anderson H, et al: Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101:806-813, 2009
19. Aricò M, Valsecchi MG, Camitta B, et al: Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342:998-1006, 2000
20. Pui CH, Gaynon PS, Boyett JM, et al: Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359:1909-1915, 2002
21. Nachman JB, Heerema NA, Sather H, et al: Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 110:1112-1115, 2007
22. Aricò M, Schrappe M, Hunger SP, et al: Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol 28:4755-4761, 2010
23. Schrappe M, Hunger SP, Pui CH, et al: Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 366:1371-1381, 2012
24. Liang DC, Yang CP, Lin DT, et al: Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia 24:397-405, 2010
25. Stark B, Nirel R, Avrahami G, et al: Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98. Leukemia 24:419-424, 2010
26. Schrappe M, Nachman J, Hunger S, et al: ‘Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)’. Leukemia 24: 253-254, 2010
27. Glantz SA: Primer of Biostatistics (ed 6). New York, NY, McGraw-Hill Medical Publications, 2005
28. Marubini E, Valsecchi MG: Analysing Survival Data From Clinical Trials and Observational Studies. West Sussex, United Kingdom, John Wiley and Sons, 2004
29. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
30. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
31. Simon R, Makuch RW: A non-parametric graphical representation of the relationship between survival and the occurrence of an event: Application to responder versus non-responder bias. Stat Med 3:35-44, 1984
32. Giovanella L, Toffalori E, Tozzoli R, et al: Multiplexed immunoassay of thyroglobulin autoanti-bodies in patients with differentiated thyroid carcinoma. Head Neck 34:1369-1371, 2012
33. Goshen Y, Stark B, Kornreich L, et al: High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49:294-297, 2007
34. Nathan PC, Ness KK, Mahoney MC, et al: Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: A report from the childhood cancer survivor study. Ann Intern Med 153:442-451, 2010
35. Trebo MM, Attarbaschi A, Mann G, et al: Histiocytosis following T-acute lymphoblastic leukemia: A BFM study. Leuk Lymphoma 46:1735-1741, 2005
36. Szczepanski T, van der Velden VH, Waanders E, et al: Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: First evidence for genetic predisposition. J Clin Oncol 29:1643-1649, 2011
37. Zhang J, Ding L, Holmfeldt L, et al: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157-163, 2012
38. Hartford C, Yang W, Cheng C, et al: Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia 21:2128-2136, 2007
39. Bolufer P, Collado M, Barragan E, et al: Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Br J Haematol 136:590-596, 2007
40. Stanulla M, Dynybil C, Bartels DB, et al: The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: A matched-pair analysis from the ALL-BFM study group. Haematologica 92:1581-1582, 2007
41. Relling MV, Rubnitz JE, Rivera GK, et al: High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354:34-39, 1999
42. Stanulla M, Schaeffeler E, Möricke A, et al: Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. Blood 114:1314-1318, 2009
43. Karran P, Attard N: Thiopurines in current medicalpractice:Molecularmechanismsandcontribu-tions to therapy-related cancer. Nat Rev Cancer 8:24-36, 2008
44. Toyoda Y, Manabe A, Tsuchida M, et al: Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood. J Clin Oncol 18:1508-1516, 2000
45. Kaspers GJ, Creutzig U: Pediatric acute myeloid leukemia: International progress and future directions. Leukemia 19:2025-2029, 2005
46. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009